Emphysematous prostatitis

Changed by Rohit Sharma, 5 Nov 2018

Updates to Article Attributes

Body was changed:

Emphysematous prostatitis refers to gas-forming infection of the prostate, nearly always occurring concurrently with prostatic abscess.

Epidemiology

The condition is rare, most commonly presenting in males aged 50-70 years, and usually confined to certain patient subgroups 1,2.

Risk factors

Risk factors include 1,2:

Clinical presentation

Clinical features are non-specific, often with lower urinary tract signs, such as dysuria, lower abdominal or perineal pain, increased urinary frequency, and urinary urgency, and systemic features of infection, such as fever 1,2. Digital rectal examination is also non-specific, with potential findings being prostatic enlargement, fluctuance, and pain 1,2.

Pathology

Emphysematous prostatitis is typically a complication of acute bacterial prostatitis, which itself is often a complication of urinary tract infections that ascend to the prostatic ducts 1-3. Causative pathogens are generally Gram negative organisms, such as Klebsiella pneumoniae (most common in one review 1), Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis 1-4.

The gas produced in emphysematous prostatitis may be produced via two mechanisms 1-4:

  • necrotic infective tissues fermenting glucose into carbon dioxide
  • gas-producing organisms

Radiographic features

Plain radiograph

Features of emphysematous prostatitis arecan be subtle on conventional radiography and may be difficult to differentiate from normal bowel gas 1-6. Typically, there will be globular regions of increased lucencyradiolucency in the area of the prostate, which is characteristically overlying the pubic rami 1-6.

Ultrasound

Transrectal ultrasound may be useful in diagnosing emphysematous prostatitis, whereby the prostate will be diffusely hypoechogenic with acoustic gas shadows 1,3,6. However, it may be difficult to differentiate gas shadows from other causes of shadows, such as prostatic calcification 1.

CT

CT is the most commonly utilised modality for diagnosing emphysematous prostatitis, and demonstrates collections of gas within the prostate parenchyma 1-6. Additionally, CT will also reveal features of concurrent acute prostatitis and prostatic abscess, which are both nearly always present 2.

MRI

Although less available than CT, MRI is also highly sensitive for demonstrating loculations of gas within prostatic parenchyma, and other concurrent pathologies as aforementioned 2,3.

Treatment and prognosis

ManagementAs it nearly always occurs alongside prostatic abscess, management is identical to that of prostatic abscess. Thus, percutaneous ultrasound-guided or CT-guided transperineal or transrectal drainage is often considered the first choice for therapy, with concurrent broad-spectrum antibiotic coverage 1,2.

The mortality rate of emphysematous prostatitis is 25%, higher than that of non-emphysematous prostatic abscess, and also higher than that of emphysematous pyelonephritis and emphysematous cystitis 1.

History and etymology

The first case was described by Albert J Mariani, an American urologist, and his colleagues in 1983 6.

  • -<p><strong>Emphysematous prostatitis</strong> refers to gas-forming infection of the <a title="Prostate" href="/articles/prostate">prostate</a>, nearly always occurring concurrently with <a title="Prostatic abscess" href="/articles/prostatic-abscess">prostatic abscess</a>.</p><h4>Epidemiology</h4><p>The condition is rare, most commonly presenting in males aged 50-70 years, and usually confined to certain patient subgroups <sup>1,2</sup>.</p><h5>Risk factors</h5><p>Risk factors include <sup>1,2</sup>:</p><ul>
  • -<li><a title="Diabetes mellitus" href="/articles/diabetes-mellitus">diabetes mellitus</a></li>
  • -<li><a title="Liver cirrhosis" href="/articles/cirrhosis">liver cirrhosis</a></li>
  • -<li>urinary retention (e.g. bladder obstruction, <a title="Neurogenic bladder" href="/articles/neurogenic-bladder">neurogenic bladder</a>)</li>
  • +<p><strong>Emphysematous prostatitis</strong> refers to gas-forming infection of the <a href="/articles/prostate">prostate</a>, nearly always occurring concurrently with <a href="/articles/prostatic-abscess">prostatic abscess</a>.</p><h4>Epidemiology</h4><p>The condition is rare, most commonly presenting in males aged 50-70 years, and usually confined to certain patient subgroups <sup>1,2</sup>.</p><h5>Risk factors</h5><p>Risk factors include <sup>1,2</sup>:</p><ul>
  • +<li>
  • +<a href="/articles/diabetes-mellitus">diabetes mellitus</a> (most common)</li>
  • +<li><a href="/articles/cirrhosis">liver cirrhosis</a></li>
  • +<li>urinary retention (e.g. bladder obstruction, <a href="/articles/neurogenic-bladder">neurogenic bladder</a>)</li>
  • -<li>recent instrumentation to the urethra or prostate</li>
  • -</ul><h4>Clinical presentation</h4><p>Clinical features are non-specific, often with lower urinary tract signs, such as dysuria, lower abdominal or perineal pain, increased urinary frequency, and urinary urgency, and systemic features of infection, such as fever <sup>1,2</sup>. Digital rectal examination is also non-specific, with potential findings being prostatic enlargement, fluctuance, and pain <sup>1,2</sup>.</p><h4>Pathology</h4><p>Emphysematous prostatitis is typically a complication of acute bacterial <a title="Prostatitis" href="/articles/prostatitis">prostatitis</a>, which itself is often a complication of urinary tract infections that ascend to the prostatic ducts <sup>1-3</sup>. Causative pathogens are generally Gram negative organisms, such as <em>Klebsiella pneumoniae</em> (most common in one review <sup>1</sup>), <em>Escherichia</em><em> coli</em>, <em>Pseudomonas aeruginosa</em>, and <em>Proteus mirabilis</em> <sup>1-4</sup>.</p><p>The gas produced in emphysematous prostatitis may be produced via two mechanisms <sup>1-4</sup>:</p><ul>
  • +<li>recent instrumentation to the <a href="/articles/urethra">urethra</a> or <a href="/articles/prostate">prostate</a>
  • +</li>
  • +</ul><h4>Clinical presentation</h4><p>Clinical features are non-specific, often with lower urinary tract signs, such as dysuria, lower abdominal or perineal pain, increased urinary frequency, and urinary urgency, and systemic features of infection, such as fever <sup>1,2</sup>. Digital rectal examination is also non-specific, with potential findings being prostatic enlargement, fluctuance, and pain <sup>1,2</sup>.</p><h4>Pathology</h4><p>Emphysematous prostatitis is typically a complication of acute bacterial <a href="/articles/prostatitis">prostatitis</a>, which itself is often a complication of urinary tract infections that ascend to the prostatic ducts <sup>1-3</sup>. Causative pathogens are generally Gram negative organisms, such as <em>Klebsiella pneumoniae</em> (most common in one review <sup>1</sup>), <em>Escherichia</em><em> coli</em>, <em>Pseudomonas aeruginosa</em>, and <em>Proteus mirabilis</em> <sup>1-4</sup>.</p><p>The gas produced in emphysematous prostatitis may be produced via two mechanisms <sup>1-4</sup>:</p><ul>
  • -</ul><h4>Radiographic features</h4><h5>Plain radiograph</h5><p>Features of emphysematous prostatitis are subtle on conventional radiography and may be difficult to differentiate from normal bowel gas <sup>1-6</sup>. Typically, there will be globular regions of increased lucency in the area of the prostate, which is characteristically overlying the pubic rami <sup>1-6</sup>.</p><h5>Ultrasound</h5><p>Transrectal ultrasound may be useful in diagnosing emphysematous prostatitis, whereby the prostate will be diffusely hypoechogenic with acoustic gas shadows <sup>1,3,6</sup>. However, it may be difficult to differentiate gas shadows from other causes of shadows, such as <a title="Prostatic calcification" href="/articles/prostatic-calcification">prostatic calcification</a> <sup>1</sup>.</p><h5>CT</h5><p>CT is the most commonly utilised modality for diagnosing emphysematous prostatitis, and demonstrates collections of gas within the prostate parenchyma <sup>1-6</sup>. Additionally, CT will also reveal features of concurrent acute <a title="Prostatitis" href="/articles/prostatitis">prostatitis</a> and <a title="Prostatic abscess" href="/articles/prostatic-abscess">prostatic abscess</a>, which are both nearly always present <sup>2</sup>.</p><h5>MRI</h5><p>Although less available than CT, MRI is also highly sensitive for demonstrating loculations of gas within prostatic parenchyma, and other concurrent pathologies <sup>2,3</sup>.</p><h4>Treatment and prognosis</h4><p>Management is identical to that of prostatic abscess. Thus, percutaneous ultrasound-guided or CT-guided transperineal or transrectal drainage is often considered the first choice for therapy, with concurrent broad-spectrum antibiotic coverage <sup>1,2</sup>.</p><p>The mortality rate of emphysematous prostatitis is 25%, higher than that of non-emphysematous <a title="Prostatic abscess" href="/articles/prostatic-abscess">prostatic abscess</a>, and also higher than that of <a title="Emphysematous pyelonephritis" href="/articles/emphysematous-pyelonephritis">emphysematous pyelonephritis</a> and <a title="Emphysematous cystitis" href="/articles/emphysematous-cystitis">emphysematous cystitis</a> <sup>1</sup>.</p><h4>History and etymology</h4><p>The first case was described by <strong>Albert J Mariani</strong>, an American urologist, and his colleagues in 1983 <sup>6</sup>.</p>
  • +</ul><h4>Radiographic features</h4><h5>Plain radiograph</h5><p>Features of emphysematous prostatitis can be subtle on conventional radiography and may be difficult to differentiate from normal bowel gas <sup>1-6</sup>. Typically, there will be globular regions of increased radiolucency in the area of the prostate, which is characteristically overlying the <a href="/articles/pubic-ramus">pubic rami</a> <sup>1-6</sup>.</p><h5>Ultrasound</h5><p>Transrectal ultrasound may be useful in diagnosing emphysematous prostatitis, whereby the prostate will be diffusely hypoechogenic with acoustic gas shadows <sup>1,3,6</sup>. However, it may be difficult to differentiate gas shadows from other causes of shadows, such as <a href="/articles/prostatic-calcification">prostatic calcification</a> <sup>1</sup>.</p><h5>CT</h5><p>CT is the most commonly utilised modality for diagnosing emphysematous prostatitis, and demonstrates collections of gas within the prostate parenchyma <sup>1-6</sup>. Additionally, CT will also reveal features of concurrent acute <a href="/articles/prostatitis">prostatitis</a> and <a href="/articles/prostatic-abscess">prostatic abscess</a>, which are both nearly always present <sup>2</sup>.</p><h5>MRI</h5><p>Although less available than CT, MRI is also highly sensitive for demonstrating loculations of gas within prostatic parenchyma, and other concurrent pathologies as aforementioned <sup>2,3</sup>.</p><h4>Treatment and prognosis</h4><p>As it nearly always occurs alongside <a href="/articles/prostatic-abscess">prostatic abscess</a>, management is identical to that of <a href="/articles/prostatic-abscess">prostatic abscess</a>. Thus, percutaneous ultrasound-guided or CT-guided transperineal or transrectal drainage is often considered the first choice for therapy, with concurrent broad-spectrum antibiotic coverage <sup>1,2</sup>.</p><p>The mortality rate of emphysematous prostatitis is 25%, higher than that of non-emphysematous <a href="/articles/prostatic-abscess">prostatic abscess</a>, and also higher than that of <a href="/articles/emphysematous-pyelonephritis">emphysematous pyelonephritis</a> and <a href="/articles/emphysematous-cystitis">emphysematous cystitis</a> <sup>1</sup>.</p><h4>History and etymology</h4><p>The first case was described by <strong>Albert J Mariani</strong>, an American urologist, and his colleagues in 1983 <sup>6</sup>.</p>

References changed:

  • 1. Wen SC, Juan YS, Wang CJ, Chang K, Shih MC, Shen JT, Wu WJ, Jang MY. Emphysematous prostatic abscess: case series study and review. (2012) International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 16 (5): e344-9. <a href="https://doi.org/10.1016/j.ijid.2012.01.002">doi:10.1016/j.ijid.2012.01.002</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22425493">Pubmed</a> <span class="ref_v4"></span>
  • 2. Kuo PH, Huang KH, Lee CW, Lee WJ, Chen SJ, Liu KL. Emphysematous prostatitis caused by Klebsiella pneumoniae. (2007) Journal of the Formosan Medical Association = Taiwan yi zhi. 106 (1): 74-7. <a href="https://doi.org/10.1016/S0929-6646(09)60219-9">doi:10.1016/S0929-6646(09)60219-9</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17282974">Pubmed</a> <span class="ref_v4"></span>
  • 3. Douglas-Moore JL, Turnbull LJ, Moazzam M, Lee ATF, Peracha AM. Emphysematous Prostatitis:. (2012) British Journal of Medical and Surgical Urology. 67 (4): 239-54. <a href="https://doi.org/10.1002/iub.1366">doi:10.1002/iub.1366</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25904163">Pubmed</a> <span class="ref_v4"></span>
  • 4. Momin UZ, Ahmed A, Nabir S, Ahmed MN, Hilli SA, Khanna M. Emphysematous prostatitis associated with emphysematous pyelonephritis and cystitis: A case report:. (2016) Journal of Clinical Urology. 5 (5): 371. <a href="https://doi.org/10.1177/1756283X10363751">doi:10.1177/1756283X10363751</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22973420">Pubmed</a> <span class="ref_v4"></span>
  • 5. Wang H-S, Shih M-C. Emphysematous Prostatitis. (2016) The New England journal of medicine. 375 (9): 879. <a href="https://doi.org/10.1056/NEJMicm1507124">doi:10.1056/NEJMicm1507124</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/27579638">Pubmed</a> <span class="ref_v4"></span>
  • 6. Mariani AJ, Jacobs LD, Clapp PR, Hariharan A, Stams UK, Hodges CV. Emphysematous prostatic abscess: diagnosis and treatment. (1983) The Journal of urology. 129 (2): 385-6. <a href="https://www.ncbi.nlm.nih.gov/pubmed/6834515">Pubmed</a> <span class="ref_v4"></span>

Tags changed:

  • cases
  • infectious diseases

Systems changed:

  • Urogenital

Updates to Primarylink Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.